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ABSTRACT Characterizing the mycobacterial transporters involved in the uptake
and/or catabolism of host-derived nutrients required by mycobacteria may identify
novel drug targets against tuberculosis. Here, we identify and characterize a mem-
ber of the amino acid-polyamine-organocation superfamily, a potential g-aminobu-
tyric acid (GABA) transport protein, GabP, from Mycobacterium smegmatis. The pro-
tein was expressed to a level allowing its purification to homogeneity, and size
exclusion chromatography coupled with multiangle laser light scattering (SEC-
MALLS) analysis of the purified protein showed that it was dimeric. We showed
that GabP transported g-aminobutyric acid both in vitro and when overexpressed in
E. coli. Additionally, transport was greatly reduced in the presence of b-alanine,
suggesting it could be either a substrate or inhibitor of GabP. Using GabP reconsti-
tuted into proteoliposomes, we demonstrated that g-aminobutyric acid uptake is
driven by the sodium gradient and is stimulated by membrane potential. Molecular
docking showed that g-aminobutyric acid binds MsGabP, another Mycobacterium
smegmatis putative GabP, and the Mycobacterium tuberculosis homologue in the
same manner. This study represents the first expression, purification, and character-
ization of an active g-aminobutyric acid transport protein from mycobacteria.
IMPORTANCE The spread of multidrug-resistant tuberculosis increases its global health
impact in humans. As there is transmission both to and from animals, the spread of
the disease also increases its effects in a broad range of animal species. Identifying
new mycobacterial transporters will enhance our understanding of mycobacterial
physiology and, furthermore, provides new drug targets. Our target protein is the
gene product of msmeg_6196, annotated as GABA permease, from Mycobacterium
smegmatis strain MC2 155. Our current study demonstrates it is a sodium-dependent
GABA transporter that may also transport b-alanine. As GABA may well be an essen-
tial nutrient for mycobacterial metabolism inside the host, this could be an attractive
target for the development of new drugs against tuberculosis.
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Tuberculosis (TB), one of the oldest and deadliest human diseases, is caused byMycobacterium tuberculosis. M. tuberculosis is a leading infectious killer, claiming
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the lives of about 1.2 million people annually (1). It is a reemerging pathogen, due to
the development of multiple-drug resistant (MDR) and extensively drug resistant
(XDR) strains (2). In addition, animal tuberculosis is a globally distributed zoonotic
chronic disease, posing a significant impact in global agricultural losses (3). Since
transmission between humans and animals has been demonstrated in both direc-
tions, TB has been described as a One Health issue, having similar consequences for
humans and animals (4), and causing huge socioeconomic impact both in terms of
human lives and resources.
The unique cell wall composition of M. tuberculosis is believed to be the major de-
terminant of its resistance to a large range of antibiotics (5), leading to a continuing
need to discover new ones. A new approach to developing therapeutics against TB is
through comprehensive discovery and characterization of metabolic pathways, their
impact on key features of M. tuberculosis pathogenesis (6), and their contribution to
drug resistance. Because M. tuberculosis has a reduced genome (7), it has neither
extended de novo synthesis pathways nor duplicated transporters, i.e., the essential
transmembrane proteins that mediate nutrient uptake and metabolite efflux (8), mean-
ing there are many essential metabolites. The transporters, required for the uptake of
essential nutrients, enable mycobacteria to persist in the harsh intracellular host envi-
ronments by scavenging nutrients. They thus represent potential new drug targets.
Characterizing unique mycobacterial transporters provides another route to discover
novel therapeutics to treat TB (9).
Despite considerable progress in the development of genetic methods for myco-
bacteria, the function of many transporters is still unknown. Nonetheless, AnsP1, an
aspartate importer, was identified by targeted mass-spectrometry-based metabolo-
mics. This method targets a predefined group of compounds and aims to determine
which one is transported. A mixture of biomolecules is introduced into the mass spec-
trometer either directly or following a separation procedure. In particular, liquid chro-
matography–mass spectrometry-based targeted metabolomics achieves high-level
sensitivity and accuracy (10). AnsP1 was shown to be involved in nitrogen metabolism
and essential for mycobacterial infection and survival (11–13). This provides evidence
that M. tuberculosis relies on amino acid uptake and degradation pathways to thrive
inside the host and confirms a strong link between nutrition and pathogenicity in M.
tuberculosis.
To identify the substrates of other orphan transporters from mycobacteria, we
adopted a similar approach for five homologous genes of AnsP1 from three different
mycobacterial species. From this initial screen, the annotated g-aminobutyric acid
(GABA) permease from Mycobacterium smegmatis MC2 155 (MsGabP hereafter) proved
promising for further studies. M. smegmatis is widely used as a convenient model sys-
tem to study M. tuberculosis biology, cell structure, and persistence under conditions of
nutrient starvation (14) because it has a higher growth rate and lower biosafety level
thanM. tuberculosis. Based on its sequence, this putative permease belongs to the amino
acid-polyamine-organocation (APC) superfamily of transport proteins (15), which is
widely found in all living organisms. To date, no in vivo or in vitro information is available
for Mycobacterium smegmatis GabP despite its being annotated as a probable GABA per-
mease based on its sequence identity to Escherichia coli GabP (16). The hydropathic pro-
file produced by the TMHMM server predicted that MsGabP has 12 transmembrane-
spanning helices (17). Homology modeling of the protein shows that it adopts an
arrangement known as the LeuT fold (18) (see Fig. S1 in the supplemental material).
In eukaryotes, besides its primary function as an inhibitory neurotransmitter (19),
GABA may have a role in the modulation of immune responses (20) but it is unclear
whether and how GABAergic signaling regulates antimicrobial host defenses during
infections. GABA does, however, act as a specific cytotoxicity and virulence regulator of
Pseudomonas aeruginosa (21). Bacteria, such as Bacillus subtilis (22), P. syringae (23), and
isolated E. coli mutants (24), can use GABA as a sole nitrogen source. Furthermore,
GABA is known to be important for acid resistance in bacteria, including E. coli (25) and
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Lactobacillus (26). In the M. tuberculosis vaccine strain Mycobacterium bovis BCG, uptake
of GABA was not induced by carbon and nitrogen starvation (27). Beyond this, the
mechanism and implications of GABA transport and metabolism have not been exten-
sively examined in mycobacteria.
We report here the successful expression of M. smegmatis MC2 155 GabP in E. coli.
SEC-MALLS analysis of the purified protein showed that it is a homodimer. Both in vitro
and in live recombinant bacteria, functional experiments allowed us to confirm predic-
tions that it is a GABA transporter. We also showed that substrate uptake by MsGabP is
sodium driven and depends on the membrane potential.
RESULTS
MsGabP expressed in E. coli. Expression of MsGabP was induced in E. coli under
the control of the IPTG (isopropyl-b-D-thiogalactopyranoside)-inducible promoter Tac.
The expression level was tested by Western blot analysis in five strains and three differ-
ent media (Fig. 1). In strains C41 (DE3) DacrB pRARE2 or C43 (DE3) DacrB pRARE2, we
observed only a very low level of expression in superbroth (SB) medium (Fig. 1, lanes
1S and 2S). Conversely, in the other strains, the expression level was higher when the
cells were cultured in SB (Fig. 1, lanes 3S, 4S, and 5S) than in LB medium (Fig. 1, lanes
3L, 4L, and 5L). Densitometry measurements (see Fig. S2 in the supplemental material)
confirmed that MsGabP shows the highest expression with BL21 Gold (DE3) pRARE2 as
the strain in SB autoinduction medium. The expression level with C41 (DE3) DacrB in
SB autoinduction medium was about 65% of that level (Fig. 1, lanes 3S and 5S). We
nonetheless chose this last condition for further optimization because AcrB, which is a
known contaminant of purified membrane protein from E. coli, is deleted in this last
strain. Following further optimization (data not shown), we determined that the opti-
mal expression conditions in C41 (DE3) DacrB strain was SB autoinduction medium for
24 h at 37°C.
The protein eluted at approximately 36 kDa on sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) despite that the predicted molecular mass is
50.7 kDa (see “Purification of MsGabP” in Materials and Methods).
Targeted metabolomics suggest GABA and serine as potential substrates of
MsGabP.We used targeted metabolomics to identify potential substrates (see Materials
and Methods). We expressed MsGabP in E. coli using the pL33 plasmid and tested for
uptake of following amino acids: GABA, arginine, lysine, aspartate, asparagine, glutamine,
glutamate, and serine. The rationale was as follows: (i) GABA because MsGabP is anno-
tated as a GABA permease; (ii) arginine and lysine because MsGabP belongs to the APC
superfamily of transporters; (iii) aspartate, asparagine, glutamine, and glutamate because
MsGabP has about 35 to 36% identity to M. tuberculosis AnsP1 and AnsP2, which trans-
port asparagine; and (iv) serine, which is polar but not charged, as a negative control.
We observed a 2-fold differential in internal GABA concentration with 1mM GABA in
energized E. coli cells containing MsGabP (Fig. 2A). Similarly, with 5mM serine, there was
FIG 1 Expression of MsGabP. The expression of MsGabP in E. coli was analyzed by Western blotting
(band migrating at ;36 kDa indicated by an arrow, detected by anti-HIS antibody). Lanes represent
MsGabP expression results in C41 (DE3) DacrB pRARE2 (1), C43 (DE3) DacrB pRARE2 (2), C41 (DE3)
DacrB (3), BL21 Star (DE3) pRARE2 (4), and BL21 Gold (DE3) pRARE2 (5). Medium types are labeled as
follows: C, LB medium containing glucose; L, LB autoinduction medium; S, SB autoinduction medium;
M9, M9 autoinduction medium. The gels were spliced for labeling purposes.
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about a 7-fold differential (Fig. 2B), suggesting these two amino acids could represent
potential substrates. No transport of the other tested amino acids was detected. For
instance, neither 1mM nor 5mM arginine and/or aspartate increased the concentration
of the respective amino acid in the MsGabP cells compared to control cells (Fig. S3).
MsGabP transports radiolabeled GABA into cells. To confirm the uptake of
potential amino acids by MsGabP, we next performed radiolabeled transport assays on
intact cells. Consistent with the metabolomics study results, E. coli cells overexpressing
MsGabP were able to take up radioactive GABA (Fig. 3). As a control, cells with empty
plasmids showed only a negligible uptake of radioactive GABA. This clearly shows that
the uptake of GABA was indeed due to the overexpressed MsGabP and not linked to E.
coli endogenous GABA transporters. In contrast, radioactive serine was not transported
by MsGabP, suggesting that serine is not a true substrate of the transporter (data not
shown). Interestingly, b-alanine, a structural analogue of GABA, competed with the
uptake of [3H]GABA into energized E. coli whole cells (Fig. 3), suggesting that it might
bind as a competitive inhibitor of GABA. GABA uptake was also significantly decreased
when a protonophore, 50 mM carbonylcyanide m-chlorophenylhydrazone (CCCP), was
added with GABA to the assay (Fig. 3), indicating that the transport depends on the
proton gradient and/or on the membrane potential.
Purification of MsGabP. We next wanted to study the transport of amino acids
with purified and reconstituted MsGabP and we therefore tested a range of detergents
for solubilization efficiency. n-Decyl-b-D-maltopyranoside (DM), n-undecyl-b-D-malto-
pyranoside (UDM), n-undecyl-b-D-thiomaltopyranoside (UDTM), and n-dodecyl-b-D-
FIG 2 Targeted metabolomics study results of GABA (A) and serine (B). The amino acids were tested with two
concentrations, 1mM and 5mM. Bars represent uptake resulting from cells harboring plasmid with MsGabP or the empty
vector control. The graphs show means (bars) and standard deviations (error bars) from three biological replicates of
one independent experiment. They are representative of two independent experiments. y axes report the ion counts
normalized on residual protein content.
FIG 3 Direct measurement of [3H]GABA uptake into E. coli cells. The transport assay was conducted
in the presence of [3H]GABA (GABA), unlabeled 5mM b-alanine added before the addition of [3H]
GABA (b-Ala), and 50mM CCCP added before the addition of [3H]GABA (CCCP). Bars represent the
GABA uptake from cells harboring plasmid with the GabP gene or empty vector. The data are means
of three measurements. Error bars indicate standard deviations.
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maltoside (DDM) at 1% all extracted MsGabP from the membranes with similar efficien-
cies (;80%), as quantified after Western blot analysis (Fig. 4A). Since DDM has a lower
critical micellar concentration (CMC) than DM, we decided to proceed with DDM for
solubilizing the protein in large-scale purification.
Preliminary purifications in DDM showed the purified protein was unstable and con-
tained contaminants (not shown). We therefore used the HRV-3C-His tag to perform
on-column detergent exchange followed by on-column cleavage to elute MsGabP to
identify detergents that stabilized the purified protein. To identify the best one, small-
scale purifications were conducted with 12 different detergents (Table 1). The stability
was then assessed by microscale fluorescent thermal stability assay (28). The protein
FIG 4 Solubilization of MsGabP. (A) Detergent solubilization screen with anti-His Western blotting of the supernatant fractions
following solubilization with CYMAL 6 (lane 1), LMNPG (lane 2), DMNPG (lane 3), OGNPG (lane 4), b-OG (lane 5), 14M (lane 6),
13M (lane 7), DDTM (lane 8), DDM (lane 9), UDTM (lane 10), UDM (lane 11), and DM (lane 12). Lane 13 is a membrane fraction
with no detergent added; M represents the protein molecular marker (in kilodaltons). (B) Microscale fluorescent thermal stability
assay of MsGabP. GabP purified with DDM at pH 7.0. Shown are data points collected during the MsGabP unfolding process
(blue) and from buffer blank control samples (black). The table shows the summary of Tm values calculated from the melting
curves. Values shown are the means of two separate measurements.
TABLE 1 Detergents tested for solubilization efficiency and MsGabP yield after detergent
exchange
Detergenta Concn (× CMC)b Concn (%)
MsGabP yield after
detergent exchange (%)c
DDM 5.7 0.05 100
CYMAL 6 3 0.084 92.3
b-OG 3 1.59 0
OGNPG 3 0.174 35.9
DMNPG 3 0.0102 83.7
LMNPG 3 0.003 0
DM 3 0.261 71.8
UDM 5 0.145 84.8
UDTM 5 0.055 90.9
DDTM 5 0.013 51.5
13M 5 0.0085 72.7
14M 5 0.0027 0
aDDM, n-dodecyl-b-D-maltoside; CYMAL, 6-cyclohexyl-1-hexyl-b-D-maltoside; b-OG, n-octyl-b-D-
glucopyranoside; OGNPG, octyl glucose neopentyl glycol; DMNPG, decyl maltose neopentyl glycol; LMNPG,
lauryl maltose neopentyl glycol; DM, n-decyl-b-D-maltopyranoside; UDM, n-undecyl-b-D-maltopyranoside;
UDTM, n-undecyl-b-D-thiomaltopyranoside; DDTM, n-dodecyl-b-D-thiomaltopyranoside; 13M, n-tridecyl-b-D-
maltopyranoside; 14M, n-tetradecyl-b-D-maltopyranoside.
bCMC, critical micellar concentration.
cValues show protein yield after detergent exchange. The number was calculated using the amount of MsGabP
obtained with 11 different detergents divided by the amount obtained from purification with DDM.
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unfolded cooperatively in DDM, decyl maltose neopentyl glycol (DMNPG), UDTM, n-do-
decyl-b-D-thiomaltopyranoside (DDTM), and n-tridecyl-b-D-maltopyranoside (13M)
(Fig. 4B) under the buffer conditions tested. This suggests that MsGabP is correctly
folded in all of these detergents. However, it was most stable in 13M or DMNPG (melt-
ing temperature [Tm] of 51.46 0.1°C and 51.26 0.2°C, respectively) (Fig. 4B), which was
about 4°C higher than in DDM (Fig. 4B). As the final yield from DMNPG was higher
than from 13M (Table 1), we used DMNGP for further experiments. Yields of ;0.7mg
protein per liter of bacterial culture were typically achieved.
Fractions collected during the protein elution from the resin showed the presence
of two bands, migrating at ;36 kDa and ;70 kDa, respectively (Fig. 5A). Peptides gen-
erated by trypsin digestion of the protein bands were analyzed using mass spectrome-
try. The acquired spectra were analyzed in PEAKS software, which allowed us to iden-
tify MsGabP with 12 unique peptides and a total sequence coverage of 14% in the
lower band at 36 kDa and 2 unique peptides and a total sequence coverage of 3% in
the upper band at 70 kDa (Fig. S4). In the lower 36-kDa band, we were able to detect
peptides from the N terminus, the middle of the MsGabP, and the C terminus, consist-
ent with a full-length protein and further supported by an active role in GABA trans-
port (see below). The 70-kDa band is either a protein homodimer or a partially folded
monomer, but most likely the latter (29).
Purified MsGabP is a dimer. The absolute molecular weight of the purified pro-
tein-detergent complex was determined by SEC-MALLS (Fig. 5B). The protein eluted as
a single, symmetrical peak at ;0.4 column volume, demonstrating its homogeneity
and monodispersion (Fig. 5B). Using the three-detector method (30), the molecular
mass of MsGabP in the main peak was found to be 79.2 kDa6 5.7%, indicating the pro-
tein is dimeric in the protein-detergent complex.
MsGabP-driven GABA transport depends on both Na1 and membrane
potential. To study MsGabP function free from E. coli metabolism and interference by
its endogenous amino-acid transporters, we reconstituted purified MsGabP into lipo-
somes. The migration (“flotation”) of proteoliposomes on a discontinuous sucrose gra-
dient demonstrated successful reconstitution of the protein into liposomes with an ef-
ficiency of ;90% (Fig. S5), as a majority of the proteoliposomes float into the 5% and
FIG 5 SEC-MALLS analysis of purified MsGabP. (A) SDS-PAGE of MsGabP eluted in DMNPG. The arrows indicate the bands on the gel
corresponding to MsGabP at ;36 kDa and ;70 kDa. (B) SEC-MALLS UV chromatogram. The colored lines indicate the molar mass
distribution of the eluting protein, detergent, and total complex. Vertical black lines indicate the part used for calculations of molar
masses.
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2.5% fractions of the gradient. We were therefore able to use these to study the trans-
port mechanism of MsGabP.
Radioactive transport assays showed there was a significantly higher accumulation
of [3H]GABA in proteoliposomes containing MsGabP compared to protein-free lipo-
somes (MsGabP versus control), when proteoliposomes loaded with K1 were diluted
into a buffer with Na1 (Fig. 6A). We were unable to measure any transport of [3H]GABA
into proteoliposomes using pH gradients alone (Fig. 6B, CCCP). In contrast, the addition
of the potassium-conducting ionophore valinomycin (31) in the transport buffer (with
Na1 present) established a negative potential inside that led to increased GABA trans-
port compared to the uptake level in the absence of valinomycin (Fig. 6B, Val). When
the membrane potential generated by valinomycin was abolished by the addition of
CCCP, the uptake activity was negligible (Fig. 6B, Val and CCCP). Importantly, when
choline chloride (ChoCl) was used in place of NaCl in the presence of valinomycin,
GABA uptake was abolished completely, indicating that Na1 was essential for transport
(Fig. 6B, Val, compare Na1 out versus ChoCl out). To confirm that the pH gradient does
not contribute to GABA transport, we trapped a membrane-impermeant fluorescent
pH indicator, pyranine, in the proteoliposomes. No change in pH was recorded upon
the addition of GABA in MsGabP-containing proteoliposomes. This confirms that pro-
tons are not involved in GABA uptake (Fig. 6C).
Phylogenetic analysis shows that E. coli GabP and B. subtilis GabP are closely
related to MsGabP and MtbGabP. A tblastn search against mycobacterial genomes
using E. coli GabP and an E value of e2100 retrieved sequences across the whole span of
mycobacteria, including sequences from the pathogenic species M. tuberculosis, M.
ulcerans, M. avium, and M. abscessus. The primary sequences of MsGabP and MtbGabP
(Rv0522) are 47% identical (56% BLOSUM62 score similar), while MsGabP and E. coli
GabP are 43% identical (62% similar). We also noted that the gene product of
FIG 6 Transport activity of the purified MsGabP reconstituted into liposomes. (A and B) Radioactive GABA uptake measured in the
presence of 200mM NaCl (A) and 200mM NaCl or 200mM choline chloride, in the presence and absence of valinomycin (5 nM) and/
or CCCP (0.03mM) (B). GABA transport was measured for 10min. (C) Monitoring of pH variation during GABA transport with
pyranine. The ratio of fluorescence at 450/400 nm is shown over time. Bars represent uptake resulting from proteoliposomes
containing MsGabP and protein-free liposome as control samples. All liposomes were loaded with 25mM HEPES (pH 6.8), including
200mM KCl. The data are means of three measurements. Error bars indicate standard deviations.
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msmeg_5473 (Ms5473 hereafter) shares 49% identity with MtbGabP and 41% identity
with MsGabP, suggesting it is also closely related to MtbGabP. Creation of a phyloge-
netic tree of bacterial protein sequences related to E. coli, B. subtilis, and M. tuberculosis
GabP showed there are two different groups of GabP sequences, each containing
members from Proteobacteria, Bacilli, and Actinobacteria. The first group includes the
sequences from E. coli (P25527), Pseudomonas syringae (Q87UE3), Bacillus subtilis GabP
(P46349), Streptomyces coelicolor (Q9L202), and Corynebacterium glutamicum AroP
(Q46065), a protein characterized as an aromatic amino acid transporter. The second
group has a less varied taxonomic distribution and comprises mainly Actinobacteria
sequences, including MsGabP and MtbGabP, but also Bacillales, Alphaproteobacteria, and
Betaproteobacteria (Fig. S6).
Docking studies suggest that the residues involved in GABA binding are
conserved between MsGabP, MtbGabP, and Ms5473. To identify potential sub-
strate-binding sites in the MsGabP, MtbGabP, and Ms5473 models (see Materials and
Methods), molecular docking of GABA to the models with grid-based ligand docking
with energetics (Glide) software (32) was performed. All predicted GABA binding poses
exhibited clusters located in the same area of the protein (Fig. S7), corresponding to
the outward-facing occluded conformation of the transporter as found in L-arginine/
agmatine antiporter AdiC (33). The residues that interact with GABA are strongly con-
served and form conserved interactions with the ligand, suggesting they are involved
in substrate binding, consistent with GABA binding to all three transporters. The side
chain of E119 (in MsGabP; E89 in MtbGabP) appears to hydrogen bond to the g-amino
group in GABA, while this interaction is absent in Ms5473. Instead, it appears to inter-
act with S297, which would be a weaker interaction (Fig. S7).
DISCUSSION
The ability of M. tuberculosis to adapt its metabolism to environmental changes,
including various stress conditions, is believed to be critical for its pathogenicity (34). It
is known that amino acids support growth of M. tuberculosis in vitro (12). However, we
lack knowledge about the regulation of amino acid transport and metabolism in myco-
bacteria. The identity of many transporters involved in this process in M. tuberculosis is
still unknown.
Here, we characterize, for the first time, the putative mycobacterial GABA permease
from M. smegmatis strain MC2 155. MsGabP is closely related to MtbGabP and M. bovis
GabP (27) (47% sequence identity) and to the previously characterized GABA perme-
ases from B. subtilis (35) and E. coli (24) (48% and 43% sequence identity, respectively).
GABA transport is an important aspect of GABA metabolism and is regulated in concert
with GABA catabolism enzymes in other bacteria. Although nitrogen-limited culture
conditions induce GABA permease expression in E. coli and B. subtilis (36, 37), the regu-
latory mechanisms are different. As in B. subtilis (22), GabP and metabolic enzymes in
mycobacteria are not physically clustered, suggesting it might exhibit functional char-
acteristics distinct from the E. coli GabP, where there is coordinated regulation of the
gab gene cluster (24, 38).
MsGabP was successfully expressed in C41 (DE3) DacrB cells grown in SB auto-
induction medium (Fig. 1) with a yield of 0.7mg/liter culture, extending the success of
using pTTQ18-based plasmids for the expression of a range of membrane transporters
(39). This provided a platform for our metabolomics and other studies. We initially
used in vivo (using a heterologous host) targeted metabolomics to identify potential
MsGabP substrates. Our metabolomics analysis suggested that GABA and serine might
both be substrates of MsGabP (Fig. 2) but that asparagine, aspartate, and lysine were
not substrates (see Fig. S3 in the supplemental material).
Further functional characterization using radiolabeled uptake assays with energized
E. coli whole cells (Fig. 3) clearly demonstrated MsGabP-mediated GABA uptake and
therefore confirmed that MsGabP is a GABA transporter. The uptake rate was in the
range of ;0.05mmol/mg cells, but it was essentially abolished (to ;0.01mmol/mg
cells) in the presence of 50mM CCCP (Fig. 3). Similarly, CCCP inhibited GABA uptake by
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nonhomologus GabP in C. glutamicum (40). We have shown, however, that GABA
uptake does not involve protons, therefore suggesting that transport is dependent on
membrane potential rather than proton gradient. GABA uptake by MsGabP was also
sensitive (;70%) to competition with b-alanine (Fig. 3), as previously observed for
both eukaryotic (41) and prokaryotic (42) GABA transporters. Unfortunately, we could
not measure uptake of b-alanine as we could not obtain it radiolabeled. Therefore, we
could not determine whether b-alanine is only a competitor or a true MsGabP sub-
strate. Interestingly, B. subtilis GabP transports b-alanine 500 times more efficiently
than the E. coli transporter, reflecting the differences in binding domains of various
GABA permeases (42).
We next aimed to purify MsGabP to perform more reliable transport measurements
in proteoliposomes. We screened for conditions that maintain protein stability and
monodispersity prior to reconstitution. Membrane protein purification strategy success
depends on the type of detergent used for solubilization and the subsequent purifica-
tion steps. The on-column detergent exchange method adopted here represents a
fast, versatile, and economical approach to screen a series of detergents (43–44).
Solubilization trials (Fig. 4A) of membrane preparation from cells with amplified
expression of MsGabP using 12 different detergents at a concentration of 1% identified
DDM as the best detergent. Although DDM can extract MsGabP efficiently from the
membrane, DMNPG was preferred for its ability to stabilize the protein and was there-
fore used in subsequent experiments.
Purified MsGabP was found to be dimeric in DMNPG (Fig. 5). This is not uncommon
among this family; mouse GAT1 appears to form both dimers and high-order oligom-
ers, as shown by in vivo FRET experiments (45). Li and colleagues (46) showed that Fos-
choline 12 (FC-12)-purified GABA transporter from E. coli is monomeric in solution. The
difference in oligomerization state is probably due to the FC-12, which is zwitterionic
and much harsher than DMNPG and so presumably denatures the protein (47, 48).
We reconstituted MsGabP into proteoliposomes with 90% efficiency (Fig. S5). The
presence of proteoliposomes in the upper fractions upon flotation on discontinuous
sucrose gradient reflects successful protein incorporation (49). Like other secondary
active transporters, substrate uptake by GABA transporter is driven by electrochemical
ion gradients (50) and the cotransported ions vary among different organisms. Direct
measurement of GABA transport with proteoliposomes showed that GABA uptake was
tightly coupled with sodium cations (Na1) (Fig. 6), as previously seen in a nonhomolo-
gus C. glutamicum transporter (40).
A phylogenetic analysis (Fig. S6) of closely related sequences to GabP showed that
this group of transporters is present across different classes of bacteria and includes
the experimentally characterized GABA transporters of E. coli, B. subtilis, and P. syringae,
although at least one member, Ncgl1062 from C. glutamicum, has been shown to be
an aromatic amino acid transporter. All Mycobacterium species analyzed have one
GabP sequence for which the phylogenetic distribution follows the evolutionary his-
tory of the genus, suggesting that it was present in the last common ancestor of all
mycobacteria. It is reasonable to assume that in this orthologous cluster, the ability to
transport GABA is preserved and that the annotation of Rv0522 as a GABA permease is
appropriate. Some mycobacteria have a second GabP sequence that was probably
acquired by lateral gene transfer from within the same group of transporters; this
includes M. smegmatis. Here, we have shown that this second member is also a GABA
transporter. Finally, structural analysis of the docked complexes revealed a similar bind-
ing pocket for GABA in all three homologues, with GABA being recognized by con-
served amino acids residues (Fig. S7). The poses for MsGabP and MtbGabP are more
similar than that of Ms5473, supporting our argument that both MsGabP and MtbGabP
are GABA transporters. We can only speculate, but MsGabP and Ms5473 may differ in
when they are expressed and/or in their relative affinities for GABA, as is the case in
Staphylococcus aureus, which has two proline transporters (51).
GABA may be an important metabolite required for mycobacterial pathogenesis,
Sodium Ions Drive Transport inM. smegmatis GabP Journal of Bacteriology
February 2021 Volume 203 Issue 4 e00642-20 jb.asm.org 9
 on F







raising the therapeutic potential of inhibitors toward GABA permease. We hope
these studies will lead to structural and further biochemical exploration of this
novel mycobacterial transporter, resulting in the discovery of new potent drugs
against TB.
MATERIALS ANDMETHODS
General. The primers used for PCR were from Sigma-Aldrich (St. Louis, MO); enzymes for cloning
were from New England BioLabs (Ipswich, MA); the reagents for the bicinchoninic acid (BCA) assay
were from Thermo Fisher Scientific (Waltham, MA); His tag-horseradish peroxidase (HRP)-conjugated
antibody was from Bio-Techne (Minneapolis, MN); detergents were from Anatrace (Maumee, OH);
and radiolabeled g-[2,3-3H(N)]-aminobutyric acid ([3H]GABA) was from Perkin Elmer (Waltham, MA).
All other chemicals were from Sigma-Aldrich (St. Louis, MO) and were of analytical grade or better.
The Mycobacterium smegmatis MC2 155 strain was purchased from ATCC (Manassas, VA), C41 (DE3)
DacrB was from Lucigen Corporation (Middleton, WI), BL21 Gold (DE3) was from Stratagene (La Jolla,
CA), BL21 Star (DE3) was from Thermo Fisher Scientific (Waltham, MA), and plasmid pRARE2 was
from Novagen (the Merck Group, Darmstadt, Germany). All media, buffers, and other solutions were
prepared using deionized water. All media were sterilized by autoclaving or, for thermally sensitive
solutions, by passage through 0.2-mm filters from Millipore.
Cloning. An expression vector pL33 for the production of MsGabP was constructed using the vector
pTTQ18 (52). pL33 encodes a C-terminal His tag preceded by an HRV-3C protease cleavage site (53). The
gene msmeg_6196 encoding GabP was amplified with M. smegmatis MC2 155 genomic DNA as the tem-
plate by PCR using the upstream primer with NheI site, 59-GCTAGCCTCGAATCGAGATCCGATCTG-39, and
downstream primer with SbfI site 59-CCTGCAGGCTCATCGGTTCTCGCAGC-39. The amplified fragment was
digested with NheI and SbfI and inserted between the corresponding sites of plasmid pL33 to construct
the expression plasmid pL33-MsGabP.
Cell growth and membrane preparation. Expression tests for MsGabP were performed using E. coli
strains C41 (DE3) DacrB, C41 (DE3) DacrB pRARE2, C43 (DE3) DacrB pRARE2, BL21 Gold (DE3) pRARE2,
and BL21 Star (DE3) pRARE2 and three different types of medium for cell growth (lysogeny broth [LB],
superbroth [SB], and M9 autoinduction medium) in 24-deep-well plates (Whatman plc, GE Healthcare, IL)
at 37°C for 24 h with shaking at 1,300 rpm (54). Isopropyl-b-D-1-thiogalactopyranoside (IPTG) induction
and autoinduction were compared to determine which condition produced more of the target protein.
Lysed cells (10mg) (54) were loaded onto SDS-PAGE gels and protein expression was determined by
Western blotting using His tag-horseradish peroxidase-conjugated antibody. Large-scale expression of
MsGabP was performed in a 30-liter fermentor (Infors HT). The cells were grown in SB autoinduction me-
dium at 37°C for 24 h and harvested by centrifugation (6,000 g, 20min, 4°C). The cells were resus-
pended in 1phosphate-buffered saline (PBS) buffer (10mM Na2HPO4, 1.8mM KH2PO4, 137mM NaCl,
and 4mM KCl [pH 7.4]) with a ratio of 6ml buffer/g cells. Membranes were prepared following the proto-
col in reference 54 and resuspended with 1 PBS buffer and total protein concentration in the mem-
brane was measured by BCA assay (55).
Solubilization and purification of MsGabP. The solubilization test was carried out at 4°C with 12
different detergents (Table 1). The membrane fraction of E. coli/MsGabP adjusted to 2mg/ml was incu-
bated in 20mM Tris (pH 8.0), 150mM NaCl, 10% (vol/vol) glycerol, and 1% (wt/vol) of the tested deter-
gent at 4°C for 1 h. Samples before and after centrifugation at 100,000 g for 1 h were analyzed by
Western blotting. Purification was started with 100mg of total membrane protein that was homoge-
nized and solubilized for 1 h at 4°C in solubilization buffer (10mM Na2HPO4, 1.8mM KH2PO4, 4mM KCl,
287mM NaCl, 7.5mM imidazole, 10% [vol/vol] glycerol, pH 7.4) with 1% (wt/vol) DDM at a protein con-
centration of 5mg/ml, followed by removal of insoluble material by centrifugation at 100,000 g for
1 h. The supernatant was incubated with 1ml HisPur cobalt resin (50% slurry) (Thermo Fisher Scientific,
Waltham, MA) and then preequilibrated with wash buffer 1 (same composition as the solubilization
buffer) containing 0.05% (wt/vol) DDM at 4°C for 2 h with gentle mixing. Immobilized-metal affinity
chromatography (IMAC) was performed by mixing the supernatant with the equilibrated resin for 2 h
with gentle mixing. The resin was then packed into the Econo-Pac disposable gravity-flow chromatogra-
phy column (Bio-Rad, Hercules, CA). Unbound material was collected followed by washing of the column
with ;10 column volumes of wash buffer 1 and 2 (differing from wash buffer 1 only by the imidazole
concentration, which was 10mM).
On-column detergent exchange. Detergent was exchanged on column from DDM into CYMAL 6,
b-OG, OGNPG, DMNPG, LMNPG, DM, UDM, UDTM, DDTM, 13M, and 14M by replacing DDM in the wash
buffer 2 with 3  CMC of each detergent. The resin then was washed with a wash buffer 3 (20mM
HEPES [pH 7.0], 100mM NaCl, 5% (vol/vol) glycerol, 3  CMC of detergent) for 8 column volume to
remove imidazole. HRV-3C protease was then added at a molar ratio of 1:1 of the target protein to the
resin with a minimal volume of wash buffer 3 and incubated at 4°C overnight to cleave the His tag. The
following day, the protein was eluted from the column using ;7ml of wash buffer 3 and then concen-
trated to a volume of ;100ml by centrifugation using a concentrator with a molecular weight cutoff of
50 kDa (Vivaspin 2; Sartorius).
Microscale fluorescent thermal stability assay. The stability of the protein purified in different
detergents was checked by microscale fluorescent thermal stability assay as described previously (28),
with the following modifications. The buffer used for dilution of the dye N-[4-(7-diethylamino-4-methyl-
3-coumarinyl)phenyl] maleimide (CPM) was the same as the buffer that the protein sample was eluted
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with. After briefly mixing the dye and the protein sample, the mixture was equilibrated at room temper-
ature for 10min while protecting it from light and then placed into the Stratagene Mx3005P Real Time
PCR machine (Agilent Technologies, Santa Clara, CA). The ramp rate was 4°C/min and the starting and
ending temperatures were 25°C and 90°C. Data were processed with GraphPadPrism for Mac (GraphPad
Software, San Diego, CA [http://www.graphpad.com/scientific-software/prism/]).
Size exclusion chromatography coupled with multiangle laser light scattering. The molecular
mass and the oligomerization state of the purified MsGabP was determined via size exclusion chroma-
tography coupled to light scattering, absorbance, and differential refractive index detectors method.
The refractive index and light scattering detectors were from Wyatt Technology (Goleta, CA) and the UV
detector and chromatography pumps from Shimadzu Corporation (Kyoto, Japan). The Superose 6 col-
umn (WTC-MP030S5; Wyatt Technology, Goleta, CA) was equilibrated with 20mM HEPES (pH 7.0), 100
mM NaCl, 5% (vol/vol) glycerol, 0.0102% (wt/vol) DMNPG overnight. Thirty microliters of MsGabP (3mg/
ml) was injected and the sample eluted from the column was analyzed by three detectors (30). Data
obtained were analyzed using ASTRA software package, version 6.1 (Wyatt Technology, Goleta, CA). The
program calculated MW,protein, MW,detergent, and MW,total throughout the peak and also provided information
on the monodispersity of the peak (56).
Targeted metabolomics study. E. coli strain C41 (DE3) DacrB harboring pL33 or pL33-MsGabP was
cultured in 50ml of LB medium at 37°C for 8 h in 250-ml shaker flasks. Cells (108) were transferred onto
mixed cellulose filters (pore size 0.22mm; Merck Millipore, Billerica, MA) by vacuum filtration and then
incubated overnight at 30°C in agar plates (1.5% (wt/vol) containing minimal medium (50mM Na2HPO4,
50mM KH2PO4, 25mM [NH4]2SO4, 2mM MgSO4, trace metals, vitamins, and 0.5% glucose) supplemented
with ampicillin (100mg ml2 1). The cells were adapted for 1 h at 37°C. Filters with the cells were trans-
ferred onto minimal medium agar (1.5% [wt/vol]) plates supplemented with the specific amino acid
tested (1mM or 5mM), 0.5mM IPTG, and ampicillin (100mg ml2 1), and incubated for 0.5 h at 37°C. The
cells were harvested and transferred to 1ml acetonitrile-methanol-water (2:2:1 vol/vol/vol) solution. The
cells were then disrupted using a bead beater and polar metabolites were extracted. After centrifuga-
tion, supernatants were collected and filtered with 0.22-mm spin-X column filters (Costar, Corning Inc.,
NY). Extracts were stored at 280°C before analysis. The amino acids tested were arginine, aspartate, as-
paragine, GABA, glutamate, glutamine, lysine, and serine. The liquid chromatography–mass spectrome-
try was performed as described previously (57). Aqueous normal phase liquid chromatography was per-
formed using an Agilent 1200LC system with a flow rate of 0.4ml/min. Elution of polar compounds was
performed using a gradient of solvents A (Milli-Q water and 0.2% acetic acid) and B (acetonitrile and
0.2% acetic acid). Accurate mass spectrometry was performed using an Agilent Accurate Mass 6230 TOF
apparatus equipped with a multimode ion source. Data were analyzed using Qualitative Analysis B.07.00
software and the metabolites were identified comparing the accurate m/z (error less than 10 ppm) and
the retention time with the accurate m/z and the retention time of standard solutions for the specific
metabolite. The ions counts were recorded and normalized to the residual protein content (detected by
BCA assay) present in each extract.
Whole-cell radiolabeled assay. C41 (DE3) DacrB E. coli was grown in M9 minimal medium supple-
mented with glycerol (20mM) and carbenicillin (100mg ml2 1) in volumes of 50ml at 37°C in 250-ml
baffled conical flasks with aeration at 200 rpm to an optical density at 680 nm (OD680) of ;0.4 to 0.6. The
cells were then either uninduced or induced with IPTG (0.5mM) for a further 1 h. Harvested cells (by cen-
trifugation at 2,500 g for 10min) were washed three times with 40ml of buffer (5mM morpholineetha-
nesulfonic acid [MES; pH 6.6], 100mM NaCl, and 50mM KCl) and then resuspended to a cell density of
A680 of;2.0. The cell suspension (196ml) containing 20mM glycerol was aerated in a bijou bottle held in
a water jacket at 37°C for 3min, and then [3H]GABA (50mM) with a specific activity of 10 mCi/ml was
added with brief mixing. Exactly 10min after adding the [3H]GABA, 80-ml aliquots were transferred to
cellulose nitrate filters (0.45mm pore size), presoaked in transport buffer on a vacuum manifold and
washed with transport buffer (6ml). The filters were transferred to scintillation vials with 10 ml emulsi-
fier-safe liquid scintillation fluid (Perkin Elmer) and incubated overnight. The level of 3H radioactivity was
measured by liquid scintillation counting (Packard Tri-Carb 2100TR instrument; Perkin Elmer, Waltham,
MA). The measured value of disintegrations per minute was converted into micromoles per milligram of
cells. Background counts were measured by washing filters under vacuum in the absence of cells or
radiolabeled substrate. Standard counts were measured by transferring 1, 2.5, 5, and 10ml of radiola-
beled substrate stock solution directly to a washed filter in the vial.
To test the effect of CCCP on transport, it was added at a final concentration of 50mM. To test the
effect on [3H]GABA uptake, unlabeled b-alanine (final concentration, 5mM) was added to the cells prior
to energizing the proteoliposomes. [3H]GABA was added 5min after and an 80-ml aliquot was taken to
measure the radioactivity.
Protein reconstitution and liposome flotation assay. The E. coli lipid extract (Avanti Polar Lipids,
Inc.) dissolved in chloroform was dried under nitrogen and the lipid film was resuspended by vortexing to
10mg/ml with reconstitution buffer (25mM HEPES [pH 6.8], including 200mM KCl and 1mM dithiothreitol
[DTT]). The dissolved lipid was then passed 11 times through 0.4-mm- and then 0.2-mm-pore-size filters
(polycarbonate Nuclepore Track Etch membrane filters) placed inside the barrel of the extruder. To desta-
bilize the liposomes and allow the insertion of the membrane protein, 1.1% b-octyl glucoside (OG) was
added to 1ml of liposomes. The purified protein was added at 500:1 lipid to protein ratio and incubated at
4°C for 1 h. This was then diluted to 15ml with a reconstitution buffer and centrifuged at 100,000 g for
1 h at 4°C. Liposome pellets were resuspended in 1ml of the reconstitution buffer. Proteoliposomes were
analyzed using a flotation assay in a sucrose gradient made of layers containing 60%, 30%, 10%, 5%, and
2.5% (mass/vol) sucrose. Proteoliposomes (250ml) were added to 250ml of 60% sucrose (in 1 HEPES
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buffer, pH 6.8). This fraction was overlaid with 0.5ml of 30% sucrose, 20%, 10%, 5%, and finally 0.4ml of
2.5% sucrose. After centrifugation at 259,000 g for 16 h, the fractions were collected from the gradient,
and analyzed for protein by SDS-PAGE.
Fluorimetric transport assay. The proteoliposomes (5ml) loaded with 25mM HEPES (pH 6.8),
200mM KCl, and 1mM pyranine dye were diluted in a buffer (1ml) containing 25mM HEPES (pH 6.8)
and 200mM NaCl and equilibrated in a stirred cuvette in the Photon Technology International QM-1
spectrophotometer (PTI, United Kingdom) for 3min. Fluorescence was monitored using 400 and 450 nm
excitation and 509 nm emission. To induce membrane potential, valinomycin was added (5 nM) at
;60 s, followed by the addition of 30mM GABA at ;160 s and 0.03mM CCCP at ;200 s. The internal pH
change was monitored as a change in the ratio of 450/400 nm pyranine fluorescence (58).
Radiolabeled assay with proteoliposomes. GABA transport was initiated by diluting 6.6ml of pro-
teoliposomes loaded with 25mM HEPES (pH 6.8)–200mM KCl buffer into 330ml of external transport
buffer: either 25mM HEPES (pH 6.8)–200mM NaCl buffer or 25mM HEPES (pH 6.8)–200mM choline chlo-
ride. To determine whether the presence of membrane potential (DW) was needed to drive GABA
uptake, 5 nM valinomycin and/or 0.03mM CCCP were added to the transport buffers. The incubation
time was about 60 s before starting the reactions by the addition of [3H]GABA (specific activity, 10 mCi/
ml) at a final concentration of 50mM. At 10min after adding the radiolabeled substrate, 80-ml aliquots
were transferred to cellulose nitrate filters (0.45mm pore size) presoaked in transport buffer on a vacuum
manifold and washed immediately with transport buffer (6ml). The filters were transferred to scintilla-
tion vials and radioactivity was measured as described for the whole-cell assay. The measured value of
disintegrations per minute was converted into picomoles per milligram of protein per minute.
Phylogenetic analysis. The sequences of Cluster of Orthologous Groups 1113 were downloaded
from EggNOG (59) and clustered using an 80% identity threshold with CD-HIT (60). An alignment was
calculated using Mafft v7.310 FFT-NS-2 (61). Sequences with less than 400 residues were removed and
the alignment was simplified to less than 85% redundancy with Jalview 2.11 (62). Both termini were
truncated to the first and the last column with 100% occupancy.
Independently, in-house scripts and BLAST1 (63) were used to mine mycobacterial and selected
model bacteria sequences using the sequence of E. coli GABA permease as query and an expected
threshold of e2100. Matches were aligned with MUSCLE (64) and the alignment was truncated and simpli-
fied to less than 95% redundancy as previously explained. Both alignments were combined using Mafft
and checked for redundancy and partial/truncated and very divergent entries were removed.
The cluster of GabP sequences was then extracted, leaving behind those of related the transporters,
e.g., AnsP (P9WQM7), CycA (O33203), YifK (P27837), ProY (P0AAE2), pheP (P24207), LysP (P25737) and
YvbW (O32257). A final alignment of this cluster was calculated using Mafft G-INS-I and consisted of 273
sequences. The best-fit evolutionary model for the alignment was LG1F1R6 as calculated by
ModelFinder (65). Maximum likelihood phylogenetic analysis was done using IQ-TREE v1.6.11 (66) with
100 standard bootstrap replicates. Phylogenetic trees were visualized with Dendroscope (67).
Molecular model of GabPs and molecular docking of GABA. De novo protein modeling of
MsGabP was performed using the Robetta server (68). The protein structures of MtbGabP and Ms5473
were homology-modeled by Phyre2 (69) using the MsGabP protein sequence as query. The rank
matches for both models had 50% identity and 100% confidence, indicating high probability of model-
ing success. The graphical user interface Maestro (version 12.4; Schrodinger LLC, New York, NY) was
used to visualize the three protein models, which were prepared for molecular modeling using the
Protein Preparation Wizard (default settings). The GABA ligand was drawn in Maestro and a low-energy,
zwitterionic conformation was generated using Ligprep (version 12.4; Schrodinger LLC, New York, NY). A
36 Å receptor grid encompassing the protein structure was generated, centered on a user-defined resi-
due (MsGabP G223, MtbGabP T193, and Ms5473 V210). Molecular docking of the GABA ligand was per-
formed on each protein model using Glide in SP mode with default settings but outputting 15 poses
(version 12.4; Schrodinger LLC, New York, NY). The predicted binding poses of the GABA ligand were
ranked by docking score and the list was visually inspected for predicted hydrogen bonding and the
associated directionality and length, steric clashes/unfavorable interactions, and ligand conformations. A
GABA-binding pose within each protein model was chosen based on the above criteria.
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